SS Innovations International Inc. Common Stock (SSII) is a publicly traded Healthcare sector company. As of July 7, 2026, SSII trades at $3.59 with a market cap of $756.50M and a P/E ratio of -61.83. SSII moved -1.47% today. Year to date, SSII is -27.99%; over the trailing twelve months it is -30.15%. Its 52-week range spans $2.48 to $22.42. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces SSII's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SS Innovations’ Training Arm Graduates First Class of 33 Cardiac Robotic Surgeons: SS Innovations’ India-based training arm SSICRS graduated 33 participants from seven countries in its inaugural cardiac robotic surgery course using the SSi Mantra system. The program featured 16 international faculty and covered procedures including endoscopic coronary bypasses, atrial septal defect repair and mitral valve surgery.
| Metric | Value |
|---|---|
| Price | $3.59 |
| Market Cap | $756.50M |
| P/E Ratio | -61.83 |
| EPS | $-0.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.42 |
| 52-Week Low | $2.48 |
| Volume | 3.12K |
| Avg Volume | 0 |
| Revenue (TTM) | $42.48M |
| Net Income | $-12.13M |
| Gross Margin | 46.00% |
1 analysts cover SSII: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.